Fasenra Injection, Solution
Product Images NDC 0310-1830

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Fasenra (NDC 0310-1830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fasenra_30mg_ml_single-dose_prefilled_syringe_carton (Fasenra 30 mg mL Carton)

Fasenra is a prescription medication that contains benralizumab and is intended for subcutaneous injection only. The prefilled syringe should be stored in a refrigerator and protected from light, between 36°F - 46°F (2°C - 8°C) and should not be shaken, frozen, or exposed to heat. The provided NDC code is 0310-1730-30.*

FDA Label Image

Fasenrapen-30mg_ml_single_dose_autoinjector_carton (Fasenrapen 30mg mL Single Dose Autoinjector Carton)

NDG 0s10-1830-30 Rxonly is a prescription medication called Fasenra Pen. It is an injection with a concentration of 30mg/mL that is stored in a refrigerator at a temperature between 2°C and 8°C. It is only for subcutaneous injection, and users should not expose it to heat or light and must follow the instructions enclosed to prepare and deliver their dose.*

FDA Label Image

Figure 2 (Figure 02)

FDA Label Image

Figure_3_change_from_baseline_fev1 (Figure 3 Change From Baseline Fev1)

This text seems to present the change in Forced Expiratory Volume in one second (FEV1) in liters for a study involving a medicine called Benraqew compared to a placebo. There are results for different time points until 56 weeks. There is also a statement indicating that Fasenra has a significant difference in relation to the placebo, with a nominal p-value of less than 0.05.*

FDA Label Image

Figure 1 Prefilled Syringe Components (Image 01)

The text describes a syringe label brand called "Needleguard" that has a needle cover and activation clips. The syringe has a plunger head and a finger flange window for viewing the needle. The body of the syringe has an expiration date.*

FDA Label Image

Step 2 Needle Cover Image (Image 02)

FDA Label Image

Step 3 (Image 03)

FDA Label Image

Step 4 (Image 04)

FDA Label Image

Step 5 (Image 05)

FDA Label Image

Step 10 Sharps Container

FDA Label Image

Step 1 Gather Supplies

FDA Label Image

Step 2 30 Minute Clock

FDA Label Image

Step 3 Fasenra Pen Viewing Window

FDA Label Image

Step 4 Choose The Injection Site

FDA Label Image

Step 5 Clean The Injection Site

FDA Label Image

Step 6 Pull Off The Cap

FDA Label Image

Step 7 A Position The Pen At The Injection Site

FDA Label Image

Step 7 B Position Press Down Firmly

FDA Label Image

Step 7 C Hold Down Firmly For 15 Seconds

FDA Label Image

Step 7 D Lift The Fasenra Pen Straight Up

FDA Label Image

Step 8 Check The Viewing Window

FDA Label Image

Step 8 Viewing Window After Injection

FDA Label Image

Step 8 Viewing Window Before Injection

FDA Label Image

Step 9 Check The Injection Site

FDA Label Image

Your Fasenra Pen After Use

After use, a needle green guard plunger is needed to maintain safety measures.*

FDA Label Image

Your Fasenra Pen Before Use

This text provides instructions for using a liquid medicine. It suggests checking the expiration date on the label and includes a reference to a viewing window, presumably to check the medicine's color or quantity. It appears to be part of the instructions for use and is likely found on the packaging or label of a liquid medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.